Publication
Title
Compulsory licensing for expensive medicines
Author
Abstract
This is a scientific report drafted in response to a tender by KCE; KCE is an independent research centre that provides scientific advice on topics related to health care to the Belgian government. The report includes a legal analysis and an economic analysis regarding the use of compulsory licensing in the context of very expensive medicines. The legal analysis first provides a descriptive analysis regarding the relevant provisions in Belgian, European and international patent law, on patenting and licensing practices and a more evaluative analysis regarding the use of compulsory licensing, in particular in the medical context. It also contains concrete suggestions and recommendations. The report was drafted at the occasion of a legislative proposal in Belgium to introduce a new compulsory licensing mechanism for such situations.
Language
English
Source (series)
KCE reports ; 356
Publication
Brussels : KCE , 2022
DOI
10.57598/R356C
Volume/pages
200 p.
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Law 
Affiliation
Publications with a UAntwerp address
External links
Record
Identifier
Creation 03.11.2023
Last edited 08.11.2023
To cite this reference